Healthcare expenditure on over-the-counter (OTC) medicines in Poland is projected to slightly decrease from 9.99% of the total current health expenditure in 2024 to 9.93% by 2028. This consistent but minimal reduction indicates a small downward trend in the relative investment in OTC medicines over this period. In 2023, the expenditure stood at 9.98%. The year-on-year variation from 2023 to 2024 is a negligible increase of 0.1%. Each subsequent year shows tiny reductions in the value, resulting in a compound annual growth rate (CAGR) indicative of a slight decline. The expected average annual variation over the five years is close to -0.1%.
Future trends to watch for include potential influences from regulatory changes, advancements in prescription medications, and evolving consumer preferences towards preventive healthcare practices, which could further impact the market share of OTC medicines within the total healthcare expenditure in Poland.
